J
Joshua A. Hill
Researcher at Fred Hutchinson Cancer Research Center
Publications - 131
Citations - 3343
Joshua A. Hill is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 23, co-authored 94 publications receiving 1708 citations. Previous affiliations of Joshua A. Hill include University of Washington Medical Center & University of Washington.
Papers
More filters
Journal ArticleDOI
Multiple early factors anticipate post-acute COVID-19 sequelae
Yapeng Su,Dan Yuan,Daniel G. Chen,Rachel Ng,Kai Wang,Jongchan Choi,Sarah Li,Sunga Hong,Rongyu Zhang,Jingyi Xie,Sergey A. Kornilov,Kelsey Scherler,A.-J. Pavlovitch-Bedzyk,Shen Dong,Christopher Lausted,Inyoul Lee,Shannon Fallen,Chengzhen L. Dai,Priyanka Baloni,Brett Smith,Venkata R. Duvvuri,Kristin G. Anderson,Jing Wei Li,Fan Yang,Caroline J. Duncombe,Denise J. McCulloch,Clifford Rostomily,Pamela Troisch,Jing Zhou,Sean Mackay,Quinn DeGottardi,Damon May,Ruth T. Taniguchi,Rachel M. Gittelman,Mark Klinger,Thomas M. Snyder,Ryan Roper,Gladys Wojciechowska,Kim Murray,Rick Edmark,Simon Evans,Lesley Jones,Yon-gan Zhou,Lee Rowen,Rachel Xia-Ying Liu,William Chour,Heather Algren,William R. Berrington,Julie A. Wallick,Rebecca Cochran,Mary Micikas,Christos J. Petropoulos,Hunter Cole,Trevan D Fischer,Wei Wei,Dave S.B. Hoon,Nathan D. Price,Naeha Subramanian,Joshua A. Hill,Jenn J. Hadlock,Andrew T. Magis,Antoni Ribas,Lewis L. Lanier,Scott D. Boyd,Jeffrey A. Bluestone,Helen Y. Chu,Leroy Hood,Raphael Gottardo,Philip D. Greenberg,Mark M. Davis,Jason D Goldman,James R. Heath +71 more
TL;DR: Huang et al. as discussed by the authors performed a deep multi-omic, longitudinal investigation of 309 COVID-19 patients from initial diagnosis to convalescence (2-3 months later), integrated with clinical data and patient-reported symptoms.
Journal ArticleDOI
Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy
Joshua A. Hill,Joshua A. Hill,Daniel Li,Kevin A. Hay,Kevin A. Hay,Margaret L. Green,Margaret L. Green,Sindhu Cherian,Xueyan Chen,Stanley R. Riddell,Stanley R. Riddell,David G. Maloney,David G. Maloney,Michael Boeckh,Michael Boeckh,Cameron J. Turtle,Cameron J. Turtle +16 more
TL;DR: Cytokine release syndrome (CRS) severity was the only factor after CAR-T-cell infusion associated with infection in a multivariable analysis and the incidence of infections was comparable to observations from clinical trials of salvage chemoimmunotherapies in similar patients.
Journal ArticleDOI
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman,Rafael de la Cámara,Christine Robin,Roberto Crocchiolo,Hermann Einsele,Joshua A. Hill,Petr Hubacek,David Navarro,Catherine Cordonnier,Katherine N. Ward +9 more
TL;DR: This Review summarises the reviewed literature and the recommendations of the ECIL 7 for management of cytomegalovirus in patients with haematological malignancies and covers diagnosis, preventive strategies such as prophylaxis and pre-emptive therapy, and management.
Journal ArticleDOI
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
Ana Cordeiro,Evandro D. Bezerra,Alexandre V. Hirayama,Joshua A. Hill,Joshua A. Hill,Qian Wu,Jenna M. Voutsinas,Mohamed L. Sorror,Mohamed L. Sorror,Cameron J. Turtle,Cameron J. Turtle,David G. Maloney,David G. Maloney,Merav Bar,Merav Bar +14 more
TL;DR: Most of the late events observed in this cohort were not severe and many could be related to prior or subsequent therapies, suggesting a safe long-term profile of CD19-targeted CAR-T cell immunotherapy.
Journal ArticleDOI
Cord-Blood Hematopoietic Stem Cell Transplant Confers an Increased Risk for Human Herpesvirus-6-Associated Acute Limbic Encephalitis: A Cohort Analysis
Joshua A. Hill,Sophia Koo,Belisa B. Guzman Suarez,Vincent T. Ho,Corey Cutler,John Koreth,Philippe Armand,Edwin P. Alyea,Lindsey R. Baden,Joseph H. Antin,Robert J. Soiffer,Francisco M. Marty +11 more
TL;DR: In this article, the authors analyzed 1344 patients undergoing allogeneic HSCT between 2003 and 2010 to identify risk factors and characteristics of acute limbic encephalitis (HHV-6-PALE) after unrelated cord-blood transplantation.